摘要
随着超声乳化技术的不断改进及白内障医师对该技术的熟练掌握,手术并发症已不再是造成白内障术后低视力的主要因素,取而代之的是术前合并的眼部病变。目前,同时患有白内障及黄斑疾病的患者不在少数,而对合并黄斑病变的白内障患者行白内障手术的风险与收益仍存在争议。不同的人工晶状体(IOL)决策会直接导致手术效果的不同。如何通过手术为合并黄斑病变的白内障患者获取最大的利益,其关键在于如何有针对性地根据患者病情把握白内障手术时机和方式以及选择最适宜的IOL。通过绘制决策树进行临床决策分析,有助于眼科医师全面地看清临床问题,为合并黄斑病变的白内障患者选择最佳治疗策略。
With the continuously improvement of phacoemulsification and mastery of this technique in cataract surgeon,complications have no longer been the main cause of postoperative low vision,replaced by preoperative combined ocular diseases. Cataract and macular diseases often occur concurrently in the same patient. The risks and benefits of cataract patients with macular diseases to receive cataract surgery are still controversial. Different decisions of intraocular lens（ IOL） lead to different outcomes of surgery directly. How to maximize benefits of cataract patients with macular diseases via surgery,the key is to take the approaches of cataract surgery at the right time and choose the appropriate IOL according to the conditions of patients individually. Making clinical decision analysis by drawing the decision tree can help ophthalmologists get comprehensive views of clinical problems and make the best treatment strategy for cataract patients with macular diseases.
出处
《中国眼耳鼻喉科杂志》
2017年第2期96-100,共5页
Chinese Journal of Ophthalmology and Otorhinolaryngology
关键词
人工晶状体
白内障手术
黄斑疾病
决策树
Intraocular Lens
Cataract surgery
Macular disease
Decision tree
